Matches in Wikidata for { <http://www.wikidata.org/entity/Q89612199> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q89612199 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q89612199 description "scientific article published on 01 March 2020" @default.
- Q89612199 description "wetenschappelijk artikel" @default.
- Q89612199 description "наукова стаття, опублікована 1 березня 2020" @default.
- Q89612199 name "Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"" @default.
- Q89612199 name "Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"" @default.
- Q89612199 type Item @default.
- Q89612199 label "Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"" @default.
- Q89612199 label "Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"" @default.
- Q89612199 prefLabel "Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"" @default.
- Q89612199 prefLabel "Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"" @default.
- Q89612199 P1433 Q89612199-3BCC4123-9D0A-41DC-91A0-C45A19D33154 @default.
- Q89612199 P1476 Q89612199-63D5B613-C86F-4DFA-9E75-7135B2AE806A @default.
- Q89612199 P2093 Q89612199-048F1B37-B133-4941-BE7B-CBD07922CB5C @default.
- Q89612199 P2093 Q89612199-8748C3BB-53F0-48EA-8A0D-3284BEDB995C @default.
- Q89612199 P2093 Q89612199-BCBDAB09-29E2-4A10-9679-A894ED326510 @default.
- Q89612199 P31 Q89612199-C8322911-8105-410A-8348-6659E94D9C9E @default.
- Q89612199 P356 Q89612199-F42368D8-C7A4-4539-93DD-B9CD8A477D20 @default.
- Q89612199 P433 Q89612199-777F4DC7-1E82-4548-858F-8C80F098E317 @default.
- Q89612199 P478 Q89612199-51D0A778-D12F-4882-B97C-3D1E39E50752 @default.
- Q89612199 P577 Q89612199-100C9975-DCB7-49F3-AC2E-6990AA46896C @default.
- Q89612199 P698 Q89612199-25F4E93D-3AF5-43C3-BF5E-FF4DC21AE154 @default.
- Q89612199 P356 DGZ134 @default.
- Q89612199 P698 32036386 @default.
- Q89612199 P1433 Q3186902 @default.
- Q89612199 P1476 "Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care"" @default.
- Q89612199 P2093 "Andrei Carvalho Sposito" @default.
- Q89612199 P2093 "Luiz Sérgio Fernandes de Carvalho" @default.
- Q89612199 P2093 "Otávio Rizzi Coelho" @default.
- Q89612199 P31 Q13442814 @default.
- Q89612199 P356 "10.1210/CLINEM/DGZ134" @default.
- Q89612199 P433 "3" @default.
- Q89612199 P478 "105" @default.
- Q89612199 P577 "2020-03-01T00:00:00Z" @default.
- Q89612199 P698 "32036386" @default.